These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25813972)

  • 1. Health security preparedness and industry trends.
    Crooke ST
    Health Secur; 2015; 13(2):74-81. PubMed ID: 25813972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic development: a victim of market forces?
    Tillotson GS
    IDrugs; 2008 May; 11(5):340-6. PubMed ID: 18465675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth industry.
    Lewis R
    Nature; 2004 Mar; 428(6980):348-9. PubMed ID: 15029202
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
    Hedner T; Gatenbeck L
    Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257
    [No Abstract]   [Full Text] [Related]  

  • 5. David Haslam. Interview by Asher Mullard.
    Haslam D
    Nat Rev Drug Discov; 2013 Jul; 12(7):500. PubMed ID: 23764976
    [No Abstract]   [Full Text] [Related]  

  • 6. Precompetitive research: a new prescription for drug development?
    Woodcock J
    Clin Pharmacol Ther; 2010 May; 87(5):521-3. PubMed ID: 20407454
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs for neglected diseases: a failure of the market and a public health failure?
    Trouiller P; Torreele E; Olliaro P; White N; Foster S; Wirth D; Pécoul B
    Trop Med Int Health; 2001 Nov; 6(11):945-51. PubMed ID: 11703850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruiters and industry.
    Jackson M
    Nature; 2004 Mar; 428(6981):450. PubMed ID: 15042100
    [No Abstract]   [Full Text] [Related]  

  • 9. Open access chemical and clinical probes to support drug discovery.
    Edwards AM; Bountra C; Kerr DJ; Willson TM
    Nat Chem Biol; 2009 Jul; 5(7):436-40. PubMed ID: 19536100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future should not look like the past.
    Lancet Infect Dis; 2006 May; 6(5):253. PubMed ID: 16631538
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical countermeasures for national security: a new government role in the pharmaceuticalization of society.
    Elbe S; Roemer-Mahler A; Long C
    Soc Sci Med; 2015 Apr; 131():263-71. PubMed ID: 24815579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global pharmacogenomics: where is the research taking us?
    Olivier C; Williams-Jones B
    Glob Public Health; 2014; 9(3):312-24. PubMed ID: 24580118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine.
    Nelson CB; Birmingham M; Costa A; Daviaud J; Perea W; Kieny MP; Tarantola D
    Am J Public Health; 2007 Apr; 97 Suppl 1(Suppl 1):S15-22. PubMed ID: 17413077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precompetitive consortia in biomedicine--how are we doing?
    Mittleman B; Neil G; Cutcher-Gershenfeld J
    Nat Biotechnol; 2013 Nov; 31(11):979-85. PubMed ID: 24213770
    [No Abstract]   [Full Text] [Related]  

  • 15. Can emerging drug classes improve R&D productivity?
    Meier C; Cairns-Smith S; Schulze U
    Drug Discov Today; 2013 Jul; 18(13-14):607-9. PubMed ID: 23702084
    [No Abstract]   [Full Text] [Related]  

  • 16. Merck opts for shake-up to clear drug pipeline.
    Nature; 2005 Dec; 438(7071):1076-7. PubMed ID: 16371975
    [No Abstract]   [Full Text] [Related]  

  • 17. High road to Scotland.
    Smaglik P
    Nature; 2004 Nov; 432(7013):128-9. PubMed ID: 15525995
    [No Abstract]   [Full Text] [Related]  

  • 18. Biocontainment laboratory risk assessment: perspectives and considerations.
    Patterson A; Fennington K; Bayha R; Wax D; Hirschberg R; Boyd N; Kurilla M
    Pathog Dis; 2014 Jul; 71(2):102-8. PubMed ID: 24591404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public vaccine manufacturing capacity in the Latin American and Caribbean region: current status and perspectives.
    Cortes Mde L; Cardoso D; Fitzgerald J; DiFabio JL
    Biologicals; 2012 Jan; 40(1):3-14. PubMed ID: 22033155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successes and failures: Worldwide vaccine development and application.
    Francis DP
    Biologicals; 2010 Sep; 38(5):523-8. PubMed ID: 20685134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.